🇺🇸 FDA
Patent

US 8343511

Methods and compositions for treating inflammatory bowel disease

granted A61KA61K31/395A61K31/435

Quick answer

US patent 8343511 (Methods and compositions for treating inflammatory bowel disease) held by RedHill Biopharma Ltd. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/395, A61K31/435, A61K31/438, A61K31/44